Federal dollars in the two health insurance programs would not go toward gender-affirming care, but states could still cover the treatments.

HHS finalized a rule prohibiting Medicaid payments for child gender medicine, including puberty blockers, cross-sex hormones, and surgeries.

El gobierno ha tomado la decisión al concluir que existen «importantes lagunas en la evidencia» que demostraba la seguridad de estos tratamientos